WallStreetZenWallStreetZen

NASDAQ: ANIK
Anika Therapeutics Inc Earnings & Revenue

ANIK past revenue growth

How has ANIK's revenue growth performed historically?
Company
7.49%
Industry
10.7%
Market
15.15%
ANIK's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ANIK's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ANIK's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ANIK earnings and revenue history

Current Revenue
$169.3M
Current Earnings
-$76.8M
Current Profit Margin
-45.4%

ANIK Return on Equity

Current Company
-31.8%
Current Industry
7.3%
Current Market
28.2%
ANIK's Return on Equity (-31.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ANIK announces earnings.

ANIK Return on Assets

Current Company
-25.8%
Current Industry
5.9%
ANIK is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ANIK Return on Capital Employed

Current Company
-34.53%
Current Industry
9%
ANIK's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ANIK vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ANIK$169.26M-$68.00M-$76.83M+9.20%N/A
CERS$191.72M-$17.20M-$31.56M+18.81%N/A
LUNG$72.99M-$50.29M-$58.73M+105.91%N/A
NVRO$430.75M-$62.39M-$82.59M+2.44%N/A
TCMD$276.67M$24.30M$28.19M+12.36%+21.87%

Anika Therapeutics Earnings & Revenue FAQ

What were ANIK's earnings last quarter?

On Invalid Date, Anika Therapeutics (NASDAQ: ANIK) reported Q1 2024 earnings per share (EPS) of -$0.31, up 56.34% year over year. Total Anika Therapeutics earnings for the quarter were -$4.51 million. In the same quarter last year, Anika Therapeutics's earnings per share (EPS) was -$0.71.

If you're new to stock investing, here's how to buy Anika Therapeutics stock.

What was ANIK's earnings growth in the past year?

As of Q2 2024, Anika Therapeutics's earnings has grown year over year. Anika Therapeutics's earnings in the past year totalled -$76.83 million.

What was ANIK's revenue last quarter?

On Invalid Date, Anika Therapeutics (NASDAQ: ANIK) reported Q1 2024 revenue of $40.52 million up 6.85% year over year. In the same quarter last year, Anika Therapeutics's revenue was $37.92 million.

What was ANIK's revenue growth in the past year?

As of Q2 2024, Anika Therapeutics's revenue has grown 7.49% year over year. This is 3.21 percentage points lower than the US Medical Devices industry revenue growth rate of 10.7%. Anika Therapeutics's revenue in the past year totalled $169.26 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.